Invest in a promising new chapter at RIT Capital Partners
The long-standing chairman of the RIT Capital Partners investment trust stepped down in 2019, but the new team are doing very well, says Max King.
Everyone likes to think that they’re indispensable. When Randolph Churchill resigned as chancellor in 1886, he expected to bring down the government. But his successor George Goschen did at least as good a job as he had done. Churchill’s career and reputation was ruined and he later admitted: “I had forgotten Goschen.”
So Jacob Rothschild may have mixed feelings about the success of RIT Capital Partners (LSE: RCP) since he stepped down as chairman in 2019. His family, who account for over 25% of the £4.2bn company, clearly benefit from the strong performance, but he may be put out that the management team are doing very well without him. Investment returns of 18% over the six months to June 2021, and 42% over 12 months, are among the best in the global sector and far ahead of the 12% and 26% returns of the MSCI All Countries index in sterling.
New investments delivering
RIT aims to deliver long term capital growth while preserving shareholders’ capital. It seeks to outperform the relevant indices “over time”, but expects to fall behind in rising markets. “RIT has slightly lagged the reference index over the last five years (to 30 June) but the volatility of performance and correlation to the index is low,” notes Chris Brown, an analyst at JPM Cazenove. The trust’s performance has accelerated in the last year, but its shares were still trading on a 6% discount to net asset value this week.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
This acceleration is largely due to the success of private equity investments, which contributed 13% of the overall 19% return in the first half. Private equity accounts for 29% of the portfolio but this excludes Coupang, the Korean e-commerce company, which listed in March and surged 40% on its debut. It accounted for 9% of the portfolio at mid-year, though its share price dropped 13% in July. It contributed 5.5% towards the first half’s overall performance.
There were several other positives in the private equity section, which includes exposure to funds as well as direct investments. A £29m new investment in stock trading platform Robinhood is doing well and the £50m investment in Webull, another trading platform in the US, looks promising. Rothschild’s absence is not limiting RIT’s access to good deals round the world; the management team are well connected and the Rothschild name is still a door opener.
The quoted equities portfolio, which accounts for 52% of the total, contributed 6% to the overall return. There has been a shift towards defensives, which might help reduce the volatility of returns, including consumer goods producers Unilever and Reckitt Benckiser. A further 20% of the portfolio is in absolute return and credit investments, which contributed 1.6% to the overall return.
Bolder decision making
The changeover from Rothschild to a younger generation has probably resulted in increased boldness in the decision making. It is hard to imagine RIT under Rothschild investing in Coupang or Robinhood, or allowing a gearing (debt to equity) ratio of around 10%. Clearly, management is positive about the outlook for the portfolio.
The only negatives are a tendency to over-hedge currency exposure into sterling (49% of the portfolio at the half year) which is costly when sterling is weak. At 1.6% fund costs are high, thanks to investment in third party funds, and there is also a management incentive scheme. These costs are an issue for many wealth managers who charge their clients additional fees, but direct investors should only be concerned about net performance, which is excellent.
My scepticism late last year was wrong. RIT should be a key building block of any investment trust portfolio.
Sign up to Money Morning
Our team, led by award winning editors, is dedicated to delivering you the top news, analysis, and guides to help you manage your money, grow your investments and build wealth.
Max has an Economics degree from the University of Cambridge and is a chartered accountant. He worked at Investec Asset Management for 12 years, managing multi-asset funds investing in internally and externally managed funds, including investment trusts. This included a fund of investment trusts which grew to £120m+. Max has managed ten investment trusts (winning many awards) and sat on the boards of three trusts – two directorships are still active.
After 39 years in financial services, including 30 as a professional fund manager, Max took semi-retirement in 2017. Max has been a MoneyWeek columnist since 2016 writing about investment funds and more generally on markets online, plus occasional opinion pieces. He also writes for the Investment Trust Handbook each year and has contributed to The Daily Telegraph and other publications. See here for details of current investments held by Max.
-
Working from home: is it working?
While Labour plans to make working from home the legal default, some employers are calling workers back into the office. What does the future hold?
By Simon Wilson Published
-
International Investment Summit: will the government's growth plans boost investor portfolios?
News The government is looking to attract investment into UK projects. We explain what this could mean for your money
By Marc Shoffman Published
-
Is Brevan Howard Macro a good investment?
Holding Brevan Howard, a world-leading vehicle through an investment trust, offers diversification on the cheap
By Rupert Hargreaves Published
-
Pfizer shares rise as US investor takes $1 billion stake
Pfizer shares are on the up since US activist investor Starboard Value built up a stake in the drug maker. But strategic options appear limited
By Dr Matthew Partridge Published
-
Is China an undervalued market?
Most funds remain wary of China amid slowing growth. Have they got it wrong?
By Max King Published
-
A fairer deal for investment trusts
New rules on how investment trusts report costs should ditch the idea that investors only need to look at one number
By Cris Sholto Heaton Published
-
Qualcomm could acquire rival Intel – but securing the deal won't be easy
A tie-up between Qualcomm and its semiconductor rival Intel would be a coup. But multiple regulatory and commercial hurdles lie ahead.
By Dr Matthew Partridge Published
-
After Priips changes, investment trusts are due a rerating
Heavy-handed rules governing fees, which put investment trust companies at a disadvantage, are to go.
By Rupert Hargreaves Published
-
Top trusts that offer growth at a discount
Professional investor Alastair Laing picks three trusts where he'd put his money
By Alastair Laing Published
-
How to invest in the quiet market months
Here's how to invest in the quiet market months, since “sell in May” hasn’t paid off this year.
By Cris Sholto Heaton Published